文献速递急性肾损伤遗传性与小管间质肾病

LDL受体相关蛋白2(megalin)作为人类肾脏抗刷状缘抗体病的靶抗原

LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease.
PubMed 文献 · J Am Soc Nephrol · 2017-10-26

患者多为老年人,表现为急性肾损伤和亚肾病性蛋白尿。血清识别分子量高的肾小管蛋白为LDL受体相关蛋白2(LRP2),即megalin,且LRP2与IgG在肾小管免疫沉积物中共定位。

要点

  • ABBA病表现为AKI、亚肾病性蛋白尿和近端小管损伤。
  • 循环抗体靶向近端小管刷状缘抗原LRP2(megalin)。
  • 肾活检可见肾小管基底膜IgG沉积,多数伴节段性肾小球沉积。

核心结论

  • ABBA病由针对近端小管刷状缘抗原LRP2的自身抗体介导,表现为AKI和亚肾病性蛋白尿。

主要发现

  • 除1例外,其余患者肾活检还可见节段性肾小球沉积。
  • 患者血清识别肾小管蛋白提取物中的高分子量蛋白,经免疫沉淀和质谱鉴定为LRP2(megalin)。
  • 免疫染色显示LRP2与IgG在ABBA活检标本的肾小管免疫沉积物中共定位,对照标本无此现象。
  • ABBA血清对重组表达的N端LRP2片段有反应性,并可免疫沉淀重组N端LRP2区域。

临床怎么用

  • 对不明原因AKI伴亚肾病性蛋白尿和近端小管损伤的患者,应警惕ABBA病。
  • 肾活检免疫荧光见肾小管基底膜IgG沉积时,可考虑检测抗刷状缘抗体。
  • 血清抗LRP2抗体可作为ABBA病的潜在诊断标志物。

局限性

  • 疾病患病率、ABBA病刺激因素及最佳治疗尚需未来研究确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary renal tubulointerstitial disease resulting from proximal tubule antigen-specific antibodies and immune complex formation has not been well characterized in humans. We report a cohort of patients with a distinct, underappreciated kidney disease characterized by kidney antibrush border antibodies and renal failure (ABBA disease). We identified ten patients with ABBA disease who had a combination of proximal tubule damage, IgG-positive immune deposits in the tubular basement membrane, and circulating antibodies reactive with normal human kidney proximal tubular brush border. All but one of the patients also had segmental glomerular deposits on renal biopsy specimen. Patients with ABBA disease were elderly and presented with AKI and subnephrotic proteinuria. Serum from all patients but not controls recognized a high molecular weight protein in renal tubular protein extracts that we identified as LDL receptor-related protein 2 (LRP2), also known as megalin, by immunoprecipitation and mass spectrometry. Immunostaining revealed that LRP2 specifically colocalized with IgG in the tubular immune deposits on the ABBA biopsy specimen but not the control specimen analyzed. Finally, ABBA serum samples but not control samples showed reactivity against recombinantly expressed N-terminal LRP2 fragments on Western blots and immunoprecipitated the recombinantly expressed N-terminal region of LRP2. This case series details the clinicopathologic findings of patients with ABBA disease and shows that the antigenic target of these autoantibodies is LRP2. Future studies are needed to determine the disease prevalence, stimulus for ABBA, and optimal treatment.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Larsen CP, Trivin-Avillach C, Coles P, et al. LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease. J Am Soc Nephrol. 2017. PMID: 29074737. doi:10.1681/ASN.2017060664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。